Diagnostic value of mitral Z-value in mortality of patients with tetralogy of Fallot: A seven-year experiment by Hekmat, Manouchehr et al.
  Journal of Cellular & Molecular Anesthesia (JCMA)  
Vol 5, No 2,  Spring 2020 
91 
Original Article  
 
 
Diagnostic Value of Mitral Z-Value in Mortality of Patients with 
Tetralogy of Fallot: A Seven-Year Experiment 
 
Manouchehr Hekmat1, Hamid Ghaderi1* , Mahnoosh Foroughi2, Sima Rafieyian3, Zahra AnsariAval2, Seyedeh 
Adeleh Mirjafari4, Kamal Fani5, Mahdi Kahrom6, Shahram Rajaei Behbahani7 
 
Abstract 
Background: Tetralogy of Fallot (TF) in some Iranian patients is different in 
that the mitral z-value is significantly lower than normal. The present study was 
conducted to investigate the effect of the mitral Z-value on post-surgery 
mortality.  
Materials and Methods: The present retrospective analytical study was 
conducted on surgery candidate patients diagnosed with TF who had attended 
Shahid Modarres Hospital in Tehran between late March 2012 and late March 
2019. Once the type of treatment and the need for surgery were decided and the 
mitral size and Z-value were determined, the patients underwent surgery, and 
then divided into two groups based on the outcome (death or discharge).  
Results: A total of 160 patients entered the study over seven years, of whom, 
110 were discharged (group 1) and 50 died (group 2). There were no 
significant differences between the two groups in terms of gender. The 
patients' mean age was 8.96±8.09 years in the group 1 and 3.16±2.7 years in 
the group 2 (P<0.000). Mean mitral Z-value was -2.26±2.11 in the group 1 
(ranging from -7.1 to +1.3) and -3.48±1.71 in the group 2 (ranging from -6 to 
-1.1), and Independent Sample Test showed no significant difference between 
the two groups (P=0.271).  
Conclusion: The mitral Z-value was significantly lower than normal in 
participating patients with TF, which could indicate hypo-plasticity of the left 
ventricle in Iranian patients with TF. No significant difference was found 
between the two groups in terms of surgical complications. In other words, the 
mitral Z-value had no effect on mortality of patients with TF.  
Keywords: Congenital heart disease, Mitral valve, Tetralogy of Fallot, Mortality, 
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Introduction 
It is generally accepted that the changes 
imposed on the heart in tetralogy of Fallot (TF) are 
associated with the right side of the heart (1-3), while 
the left ventricle is overlooked, and most studies are 
concerned with the right ventricle, changes in its size, 
and its effect on the restoration outcomes (3). 
However, with recent advances in diagnostic and 
treatment methods, more attention is paid to the left 
ventricle and its effect on the short- and long-term 
1. Department of Cardiovascular 
Surgery, Shahid Modarres Hospital, 
Shahid Beheshti University of Medical 
Sciences, Tehran, Iran 
2. Clinical Research and Development 
Center at Shahid Modarres Hospital, 
Department of Cardiac Surgery, 
Shahid Beheshti University of Medical 
Sciences, Tehran, Iran 
3. Department of Pediatric Cardiology 
and Pediatric Cardiac Surgery, Shahid 
Modarres Hospital, Shahid Beheshti 
University of Medical Sciences, 
Tehran, Iran 
4. Department of Pediatrics, Ali-
Asghar Children`s Hospital, Iran 
University of Medical Sciences, 
Tehran, Iran 
5. Department of Anesthesiology, 
Shahid Modarres Hospital, Shahid 
Beheshti University of Medical 
Sciences, Tehran, Iran 
6. Department of Cardiovascular 
Surgery, Faculty of Medicine, 
Mashhad University of Medical 
Sciences, Mashhad, Iran 
7. Department of Pediatrics, Division 
of Pediatric Cardiology, Golestan 
Hospital, Ahvaz Jundishapur 
University of Medical Sciences, 
Ahvaz, Iran 
Corresponding Author: Hamid 
Ghaderi, M.D. Department of 
Cardiovascular Surgery, Shahid 
Modarres Hospital, Shahid Beheshti 
University of Medical sciences. Tel: 




Hekmat et al.                                                                              Diagnostic Value of Mitral Z-Value in Mortality of … 
 Journal of Cellular & Molecular Anesthesia (JCMA) 
92 
outcomes (4, 5). A study conducted on Iranian patients 
with TF in 2012 showed significantly lower mitral Z-
values than normal, suggesting hypo-plasticity of the 
left ventricle in these patients (the standard is 0±2 SD, 
which is -3.09±2.11 in Iranian patients with TF, 
ranging from +1.3 SD to -7.1 SD) (6). No study has yet 
investigated the mitral Z-value in patients with TF or 
its outcome.  
The present study aims to determine if there is a 
relationship between mitral Z-value and postsurgical 
mortality of patients with TF, and whether it can be 
used as a predictor of mortality?. 
Methods 
The study protocol was assessed and approved 
by Institutional Ethics Board, coded 
IR.SBMU.RETECH.REC.1399.675, Deputy of 
Research, Shahid Beheshti University of Medical 
Sciences, Tehran, Iran. 
This was a retrospective analytical study, 
conducted on surgery patients diagnosed with 
Tetralogy of Fallot (TF) whether with initial or 
previous diagnosis for surgery, Modarres Hospital, 
Tehran, between March 2012 to March 2019. The 
same pediatric cardiologist measured all 
echocardiographic criteria, and the same surgeon 
conducted the surgery. According to the study 
inclusion criteria, any patient with TF and candidate 
for surgery was included.  
The pediatric cardiologist jointly made decision 
and a cardiac surgeon about treatment of hospitalized 
patients diagnosed with TF. Then, the same pediatric 
cardiologist carried out echocardiography; mitral Z-
value determined was made available to the researcher. 
To avoid errors, mitral Z-value was measured in 
several cardiac cycles and in 4- chamber and 2-
chamber views; the mean was used as Z-value. Once 
the mitral size and body surface area (BSA) were 
determined, Z-value was defined as standard Z-value 
graphs. 
Since the mitral Z-value currently has minimal 
effect on the surgeon's decision about the surgical 
method, it was not given to the surgeon until the end of 
surgery. The diagnosis of TF was confirmed in the 
course of surgery. Other data and the outcome were 
included in the questionnaire. 
In the present study, we evaluated the following 
variables: Age, gender, height, weight, BSA, mitral 
valve size, Z-value (Z score or Z-value was determined 
after finding the mitral size by echocardiography and 
BAS, based on the available standard graph), and other 
concomitant anomalies, frequency of surgery, type of 
previous surgeries, type of current surgery, and final 
outcome. Considering the study was conducted over a 
short period and completed before discharge, we did 
not have withdrawal and loss of patients. After 
completion of each patient's special form, the related 
data were inserted into a code sheet.  
The present study was conducted in accordance 
with the Helsinki Declaration principles and the 
checklist of ethics in research. For each patient, the 
informed consent form was completed and included in 
their record. The patients received the best available 
treatment, and hence, no change was made in their 
current treatment regimen, and no extra cost, pain, or 
procedure was imposed on them.  
In the present study, all data were collected by 
the same person (cardiac surgery subspecialist), and 
analyzed in SPSS-18 (IBM, SPSS, Armonk, NY, 
USA). 
Results 
A total of 160 patients entered the study over 
seven years, who were divided into two groups based 
on whether they survived after surgery (group 1) or 
died (group 2). 
In terms of gender, group 1 (Alive) included 46 
males and 64 females, and group 2 included (Dead) 12 
males and 38 females), with no significant difference 
between the two groups (based on Chi-square test, 
P=0.124). 
Their mean age was 8.96±8.09 years in group 1 
(Alive) ranging from 1 to 34 years, and 3.16±2.7 years 
in group 2 (Dead) ranging from 1 to 10 years (P<0.000 
according to Independent Sample test). 
Furthermore, the two groups were compared in 
terms of height, weight, and BSA (Table 1). 
In the course of surgery, duration of 
Cardiopulmonary Bypass and Aortic clamp was 
determined, and CPB was found 91.84±39.04 minutes 
in group 1 and 130±30.02 minutes in group 2, with a 
significant difference between the two groups 
(P<0.028), while they were not significantly different 
in terms of aortic clamp time (P=0.062; Table 1). 
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The patients' mitral size was measured using 
echocardiography, which was 17.69±6.42mm in the 
group 1 (Alive) and 12.92±9.98mm in the group 2 
(Dead), with a significant difference between them 
(P<0.000) (Table 2). However, no significant 
difference was observed between the two groups when 
the mitral size was measured based on BSA to 
determine Z-score (P=0.127), and the following data 
were obtained: 
The mitral Z-score was -2.91±6.26 ranging from 
-7.1 to +1.3 in the group 1 (Alive), and -3.48±1.71 
ranging from -6 to -1.1 in group 2 (Dead) (Table 2). Of 
160 patients, 116 (72.5%) only had TF, and 44 (27.5%) 
also had other anomalies (30 patients from group 1 and 
14 from group 2), with no significant difference 
between two groups (P=0.946); Table 3.  
Of the 110 patients in group 1, only 58 were 
undergoing surgery for the first time. Thirty of them 
for the second time and 22 for the third time. Of the 50 
patients in the group 2, 32 were undergoing surgery for 
the first time, 14 for the second time, 2 for the third 
time, and 2 for the fourth time. However, there was no 
significant difference between the two groups (Chi-
square test, P=0.137). 
Shunt surgery was most frequent among the 70 
patients who had previously undergone surgery with 
30 cases (42.9%), followed by Total Correction of 
Tetralogy of Fallot (TCTF) with 24 cases (34.3%) 
(Table 4). Out of the 160 patients, 118 (73.8%) 
underwent TCTF, 34 (21.3%) underwent surgery, and 
8 (5%) had Shunt surgery, as shown by groups in Table 
5. All patients in the group 2 (Dead) underwent TCTF, 
and no mortality was observed in other surgeries.  
Duration of hospital stay (from surgery to 
discharge or death) was 7.86±6.26 days, which was 
10.98±5.06 days in the group 1 (Alive), but all group 2 
(Dead) patients died in the first 24 hours in surgery 
room or ICU (Table 1). Of the 50 patients who died in 
the first 24 hours, 36 (72%) were in the surgery room 
and 14 (28%) in ICU. 
Table 1: The groups' demographic distribution, data during surgery, in patients with tetralogy of Fallot attending Shahid 
Modarres Hospital between late march 2012 and late march 2019. 
 Groups  Mean  Minimum  Maximum  P* 
Age (years) Group 1 (Alive) 8.96±8.09 1 34 
P<0.000 
Group 2 (Death) 3.16±2.71 1 10 
Height (cm) Group 1 (Alive) 126.63±33.56 75 182 
P<0.000 
Group 2 (Death) 87.88±16.31 70 122 
Weight (Kg) Group 1 (Alive) 27.76±20.68 8 79 
P<0.000 
Group 2 (Death) 10.58±3.69 6 19 
BSA (m2) Group 1 (Alive) 0.931±0.488 0.42 2 
P<0.000 
Group 2 (Death) 0.512±0.127 0.35 0.8 
CPB (Minutes) Group 1 (Alive) 91.84±39.04 23 141 
P<0.028 
Group 2 (Death) 130±30.02 116 198 
XC (Minutes) Group 1 (Alive) 61.10±34.49 15 112 
P=0.062 




Group 1 (Alive) 10.98±5.06 5 27 
P<0.000 
Group 2 (Death) 1 1 1 
*Using Independent Sample test; CPB: Cardio Pulmonary Bypass; XC: Aortic Cross Clamp  
Table 2: Frequency distribution of mitral size and mitral Z-value in groups of patients with tetralogy of Fallot in Shahid 
Modarres Hospital; March 2012 to March 2019. 
 Groups  Mean Minimum Maximum P* 
Mitral size (mm) Group 1 (Alive) 17.69±6.42 10 27 
P<0.000 
Group 2 (Death) 12.92±2.98 10 19 
Mitral Z-value Group 1 (Alive) -2.91±2.25 -7.1 +1.3 
P=0.271 
Group 2 (Death) -3.48±1.71 -6 -1.1 
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Table 3: The groups' demographic distribution, data during surgery, in patients with tetralogy of Fallot in Shahid Modarres 
Hospital; March 2012 to March 2019. 




                                                      Results 
Type of anomaly 
(72.5%) 116 36 80 Tetralogy of Fallot 
(3.8%) 6 6 0 TF + DTCA + DORV + PS 
(2.5%) 4 4 0 TF + DORV + PDA 
(2.5%) 4 4 0 Right Aortic Arch 
(7.5%) 12 0 12 TF + Pulmonary Atresia + L-TGA + ASD 
(3.8%) 6 0 6 TF + PDA + Cleft Lip 
(3.8%) 6 0 6 TF + Cleft Lip 
(3.8%) 6 0 6 Down Syndrome 
160 50 110 *Total 
 P value for Chi Square test=0.946 
TF: Tetralogy of Fallot, DTGA: D- Transposition of the Great Arteries, DORV: Double Outlet Right Ventricle, PS: pulmonary stenosis 
PDA: Patent Ductus Arteriosus, ASD: Atrial Septal Defect, L-TGA: L- Transposition of the Great Arteries 
 
 
Table 4: Frequency distribution of type of previous surgery in patients with TF in Shahid Modarres Hospital; March 2012 
to March 2019. 
Total * Group 2 (Death) 
Group 1 
(Alive) 
                                                             Groups  
Type of previous surgery 
(42.9%) 30 12 18 Shunt 
(34.3%) 24 0 24 TCTF 
(8.6%) 6 6 0 RVOT Repair 
(8.6%) 6 0 6 Shunt + Rastelli operation With Homograft 
(5.7%) 4 0 4 Shunt + TCTF 
70 18 52 Total 
 P value for Chi Square test=0.03 
TCTF: total correction of: Tetralogy of Fallot. RVOT: Right Ventricle out flow tract 
 
Table 5. Frequency distribution of type of surgery in patients with TF in Shahid Modarres Hospital; March 2012 to March 
2019 
Total* Group 2 (Death) Group 1 (Alive) 
                         Groups 
Type of surgery 
(73.8%) 118 50 68 TCTF 
(21.3%) 34 0 34 PVR 
(5%) 8 0 8 Shunt 
160 50 110 Total 
 P value for Chi Square test=0.02 
TCTF: Total correction of Tetralogy of Fallot. 





A total of 160 patients underwent surgery for TF 
in Shahid Modarres Hospital over seven years, who 
were divided into two groups, 110 in group 1 (Alive) 
and 50 in group 2 (Dead).  
In terms of gender, 58 (36.3%) of patients were 
male, and 102 (63.8%) female, with no significant 
difference between the two groups (P=0.124), which 
concurs with other studies on TF. The gender 
proportion also matched other studies (3, 6, 7). 
In terms of distribution of age, the patients' 
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mean age was similar to that in other studies (6, 8). 
However, mean age by groups was 8.96±8.09 in-group 
1, and 3.16±2.7 in-group 2, suggesting that mean age 
was lower in group 2 patients (leading to death) and 
that they were in a critical state. 
In a study by Amorim et al. (2005) on 66 
patients with TF (7), mean age was 4±5 years in 
palliative surgery group and 10±8 years in TCTF 
group.  
Mean age was 3.16±2.7 years in the group 2 
patients, who had all undergone TCTF surgery. 
Although TCTF has been performed for four decades 
(3, 7) and improvement in surgical techniques in recent 
years has enabled most centers to perform TCTF in 
infant patients with TF (3), for the present study center 
and similar centers, palliative treatment appears to be 
a better initial option at lower ages, and TCTF should 
be performed when the child is older. As in recent 
studies (7), mean age at diagnosis and initial surgical 
treatment of TF was 6.6±7.6 years.  
Due to the older age of group 1 patients, there 
were significant differences between the two groups in 
terms of height and weight. Also, due to older age and 
size of group 1 patients, their BSA and mitral size were 
higher, and the mitral Z-value was used to neutralize 
these effects. 
Although it has been accepted that in TF, the left 
ventricle wall thickness is normal and its volume is 
normal or below normal (4-13), and the left ventricle 
size and mitral valves are rarely hypo-plastic, in the 
present study, the mitral valve Z-value was less than 
normal (which should normally be SD 0±2) (3). This 
finding suggests that contrary to existing data on TOF, 
the mitral Z-value and consequently the left ventricle 
size in the present study patients with TF are less than 
globally reported values (3, 10, 11, 14, 15). This 
difference is perhaps due to a different type of TF in 
Iran with smaller left ventricle size and Z-value 
(10).Line in some diseases such as TF, VSD site is 
different in Asian types (3).  
Although the mitral Z-value in patients with TF 
was lower than normal, Z-value in-group 1 (Alive) was 
not significantly different group 2 (Dead) (P=0.271) 
and was insignificant.  
CPB>120 minutes and aortic cross clamp 
time>90 minutes are variables that indicate a higher 
mortality rate in patients with TF (9), and these results 
were confirmed in the present study, in which CPB was 
130+30.02 minutes and aortic cross clamp time was 
90.5+32.53 minutes in group 2 (Dead). 
In the present study, 44 patients (27.5%) had 
concomitant anomalies. Various studies have reported 
different statistics of concomitant anomalies from 30% 
to 60% depending on which cases are considered as an 
anomaly (6, 8, 9). 
A review of 50 studies conducted over 40 years 
showed higher surgery-induced mortality in patients 
with TF with Complete Atrioventricular Septal Defect 
(16).  
Down syndrome was another risk factor for 
early mortality (17). In the present study, six patients 
(3.8%) (All in-group 1) had Down syndrome. 
Moreover, although Multiple Ventricular Septal 
Defect is seen in 1% to 3% of patients with TF with 
pulmonary stenosis, its presence is considered to be a 
strong predictor of mortality (17). 
In the present study, 90 patients (53%) in total 
were undergoing surgery for the first time, and the rest 
for the second, third and fourth time. However, the 
reoperation figure is different in domestic and foreign 
studies. While 40% of patients underwent surgery 
again in domestic studies (9), only 9% (3) in foreign 
studies were reoperated, where TCTF at early ages 
tends to have low mortality (18). 
The studies conducted to determine risk factors 
for mortality showed that one previous operation for 
classic shunt is not considered a risk factor, but more 
than one palliative operation is (19). 
Although in the present study, no significant 
difference was observed between the two groups in 
terms of number of previous operations (P=0.137), the 
difference between them was significant in terms of 
type of previous operation (P<0.03). 
Given the present study limitations and 
difficulties, the following cases are recommended for 
future studies: 
1. Through a complete study, normal level and standard 
deviation of the heart anatomical sizes should first be 
determined for Iranians, and sizes and standard 
deviations should be assessed against them (normal Z-
value for Iranians). 
2. The same study should be repeated by a specific 
echocardiologist and different cardiac surgeon to see if 
the mitral Z-value and size are lower in patients with 
TF from other centers or not. 
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Given that the risk of death increases three to six 
months after TF surgery, and then the risk flattens for 
the same 30-day hospital mortality, the risk of 
mortality of patients with TF is estimated less than the 
actual rate. Thus, it is recommended to conduct a study 
with six-month follow-up periods. 
Conclusion 
In patients with TF undergoing surgery at 
Modarres Hospital, mean mitral Z-value was 
significantly lower than the expected and accepted 
value. However, no significant difference observed 
between two groups of patients (Alive and Dead). 
Perhaps there is a different type of TF in Iran that has 
smaller Z-value and ventricle size (this may be one of 
the reasons for higher rates of early mortality in Iranian 
patients with TF undergoing surgery). In the present 
study, no significant difference was observed between 
the two groups in terms of mitral Z-value. However, it 
can be seen from the tables that patients with higher 
mitral Z-values were in a better state than those with 
lower Z-values. 
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